Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Galapagos Delivers Candidate in Janssen Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Galapagos Delivers Candidate in Janssen Alliance

Triggers $8.7 million milestone payment

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Galapagos NV has identified a preclinical compound in its alliance with Janssen Pharmaceutica NV, triggering an $8.7 million milestone payment to Galapagos. Galapagos developed the preclinical candidate against a novel target discovered using its proprietary platform. Galapagos will now begin safety evaluation to advance the compound to Phase I trials.

“Four years into the alliance, which started at the novel target stage, we are excited to have delivered the first preclinical candidate,” said Onno van de Stolpe, chief executive of Galapagos. “Our alliances with pharma provide financing to survive industry standard attrition and get a certain percentage of programs through to the clinic. In this way, Galapagos continues to build a strong R&D track record by efficiently delivering high quality results, both in its alliance and proprietary therapeutic pipelines.”

Under the alliance that began in October 2007, Janssen Pharmaceutica has option rights to acquire worldwide, commercial licenses to certain Galapagos internal programs. Galapagos is eligible to receive as much as EUR73 million in milestones per program, plus royalties. To date, Galapagos has received EUR31 million from Janssen Pharmaceutica.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics